Monocyte derived Galectin-9 and PD-L1 differentially impair innate and adaptive immune response in various phases of chronic HBV infection

Author:

Dey Debangana1,Biswas Satabdi1,Pal Sourina1,Nandi Sarthak1,Khatun NAJMA1,Jha Rambha1,Chakraborty Bidhan Chandra1,Baidya Ayana1,Ghosh Ranajoy1,Banerjee Soma1,AHAMMED SK MAHIUDDIN1,Chowdhury Abhijit1,DATTA SIMANTI2ORCID

Affiliation:

1. IPGMER: Institute of Postgraduate Medical Education and Research

2. Institute of Postgraduate Medical Education and Research

Abstract

Abstract Background and aims: Patients with chronic HBV infection (CHI) exhibit defective anti-viral immune-response whose underlying mechanisms remain unclear. Monocytes can regulate immunity via interaction with other immune-cells apart from differentiating into macrophages. Immune-checkpoint molecules (ICMs) expressed by different immune-cells, including monocytes negatively regulate immune-responses. We evaluated the expression of ICMs (Gal-9/PD-L1/CTLA-4) on monocytes in different phases of CHI, identified viral/host-factors causing their aberrant expression and investigated their impact during interaction of monocytes with T-/B-/NK-cells and macrophage differentiation. Effect of antiviral-therapy on ICMs was studied. Methods: Collection of blood/liver-tissue samples/flow-cytometry/cell-sorting/cell-culture/immune-fluorescence were performed. Results: Gal-9+/PD-L1+-monocytes were significantly increased in HBeAg-positive/HBeAg-negative chronic hepatitis B (CHB) patients than healthy controls (HC). In immune-tolerant (IT) subjects, Gal-9+-monocytes and in inactive carriers (IC), PD-L1+-monocytes were higher than HC while CTLA-4+-monocytes remained comparable among groups. High serum Hepatitis B surface antigen (HBsAg) concentration in IT/CHB and TNF-α in CHB triggered monocytic Gal-9-expression whereas high TNF-α/IL-4 in CHB and IL-1β in CHB/IC potentiated PD-L1 induction. Purified monocytes from CHB/IT having high Gal-9 expression led to expansion of CD4+CD25+FOXP3+-Tregs/CD19+CD27-CD21--atypical memory B-cells/CD19+IL-10+-Bregs and they preferentially differentiated into M2-macrophages. Anti-Gal-9-antibody reversed these phenomena. Parallelly, PD-L1+-monocytes in CHB/IC reduced IL-2/IFN-γ and IL-6-production by HBcAg-specific CD4+/CD8+T-cells and B-cells respectively, which were restored by anti-PD-L1-antibody. Gal-9+-/PD-L1+-monocytes caused decline in IFN-γ+-NK-cells but enhanced IL-10+-NK-cells and HBV-specific-T-cells. Increased intrahepatic CD14+Gal-9+/CD14+PD-L1+-monocytes was noted in CHB patients. One-year tenofovir-therapy failed to reduce monocytic Gal-9/PD-L1-expression and HBsAg/TNF-α/IL-4/IL-1β levels. Conclusion: Monocyte-derived Gal-9/PD-L1 exert distinct inhibitory effects in different phases of CHI and their therapeutic targeting could boost anti-HBV immunity.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3